Table 2.
Outcomes measures
| Variables | Overall n=79 | SAPB group n=43 | ESPB group n=36 | P |
|---|---|---|---|---|
| NRS 12 h | 0.50 (0.00-3.00) | 0.00 (0.00-3.50) | 1.00 (0.00-2.00) | 0.93 |
| NRS 24 h | 0.00 (0.00-2.00) | 0.00 (0.00-3.50) | 0.50 (0.00-2.00) | 0.41 |
| NRS 48 h | 0.00 (0.00-2.00) | 1.00 (0.00-3.00) | 0.00 (0.00-2.00) | 0.17 |
| Morphine consumption 24 h (mg) | 0.00 (0.00-2.00) | 0.00 (0.00-0.00) | 0.00 (0.00-0.75) | 0.76 |
| Morphine consumption 24-48 h (mg) | 0.00 (0.00-0.00) | 0.00 (0.00-0.00) | 0.00 (0.00-0.00) | 0.013* |
| Morphine total consumption (mg) | 0.00 (0.00-3.00) | 0.00 (0.00-4.00) | 0.00 (0.00-3.00) | 0.38 |
NRS: numeric rating scale; Morphine tot: total morphine consumption (continue infusion + rescue dose); Morphine consumption 24 h: total morphine doses in the first 24 postoperative hours; Morphine consumption 24-48: total morphine doses between 24 and 48 postoperative hours; SAPB, serratus anterior plane block; ESP, erector spinae plane block; *, significant result; Note: Results are presented as means with 95% confidence intervals